Privia Health Group Inc
PRVA
NGS
Sector: Manufacturing
Industry: Dental Laboratories
36.63
USD
-1.24
(-3.27%)
Optionable: Yes Market Cap: 3,997 M 90-day average vol: 864,372
Previous close: 37.87 Open: 38.62 Bid: 36.7 Ask: 36.7
52 week range
17.99 41.85
Last updated: Sunday 14th August 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Metrics
Valuation
Price per Sales TTM ($) | 4.76 |
Price per Book TTM ($) | 9.42 |
PE Ratio (TTM) | -18.70 |
Book Value per Share ($) | 4.01 |
5 Year PE Range | -14.1 , -14.7 |
Returns
7 Day Return | -2.86% | |
1 Month Return | 6.76% | |
3 Month Return | 60.80% | |
1 Year Return | 13.06% | |
3 Year Return | 5.41% | |
5 Year Return | 5.41% | |
YTD Return | 41.59% |
Risk
Analyst Estimates
Financial Health
Technicals
RSI (14 Day) | 55.19 |
14 Day SMA ($) | 37.38 |
14 Day EMA ($) | 36.98 |
Money Flow Index | 42.72 |
Average True Range | 2.09 |
50 Day SMA ($) | 32.18 |
200 Day SMA ($) | 26.44 |
ADX | 18.10 |
MACD | 1.50 |
Growth
Free Cash Flow QoQ Growth | 0.00% |
Free Cash Flow YoY Growth | 0.00% |
Revenue YoY Growth | 0.00% |
EPS QoQ Growth | 0.00% |
Revenue QoQ Growth | 0.00% |
EPS YoY Growth | 0.00% |
Profitability
Chart
News
Privia Health to Participate in SVB Leerink Virtual Healthcare Conference
Yahoo Finance 2/15/2022
Privia and Javara collaborate in Moderna’s vaccine study for respiratory syncytial virus
Seeking Alpha 2/14/2022
Javara Contributes to RSV Prevention Vaccine Trial in Collaboration with Privia Health and Moderna
Yahoo Finance 2/14/2022
An Intrinsic Calculation For Privia Health Group, Inc. (NASDAQ:PRVA) Suggests It's 50% Undervalued
Yahoo Finance 2/7/2022
Privia Health Group: Not Healthy Yet
Seeking Alpha 2/6/2022
Privia Health Partners with Surgery Partners; Enters Montana Market
Yahoo Finance 2/3/2022
Surgery Partners Enters Strategic Partnership with Privia Health in the State of Montana
Yahoo Finance 2/3/2022
C WorldWide Group Holding A Buys Adobe Inc, Align Technology Inc, NovoCure, Sells Visa Inc, ...
Yahoo Finance 2/2/2022
Privia Health to Report Fourth Quarter 2021 Results on Friday, March 25
Yahoo Finance 1/31/2022
Privia Health Launches Three New Accountable Care Organizations
Yahoo Finance 1/26/2022
Privia Health (PRVA) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference
Seeking Alpha 1/24/2022
Encompass Wealth Advisors, Llc Buys AbbVie Inc, Coca-Cola Co, Freeport-McMoRan Inc, Sells Tesla ...
Yahoo Finance 1/20/2022
Riverbridge Partners Llc Buys Amedisys Inc, Privia Health Group Inc, Progyny Inc, Sells Gentex ...
Yahoo Finance 1/15/2022
Privia Health hires new CFO
Seeking Alpha 1/6/2022
Jeff Sherman Joins Privia Health as Chief Financial Officer
Yahoo Finance 1/6/2022
Privia Health inks capitated Medicare advantage agreements with Humana, HealthFirst
Seeking Alpha 1/5/2022
Privia Health Enters into Capitated Medicare Advantage Agreements
Yahoo Finance 1/5/2022
Privia Health to Participate in 40th Annual J.P. Morgan Healthcare Conference
Yahoo Finance 1/4/2022
Trend Analysis & Forecast
Read more on this trend analysis & forecast here - uptrenddowntrend.com
Trendlast: 12.147
Financials
PRVA Income Statement
Annual
| Invalid date | Dec-18 | Dec-19 | Dec-20 | Dec-21 | |
|---|---|---|---|---|---|
| Total revenues | 658 M | 786 M | 817 M | 966 M | |
| Cost of sales | 600 M | 716 M | 733 M | 900 M | |
| Gross operating profit | 54 M | 65 M | 64 M | 58 M | |
| Selling Gen & administrative expense | 53 M | 51 M | 55 M | 279 M | |
| Research & development expense | 0 | 0 | 0 | 0 | |
| Operating income | 2 M | 16 M | 25 M | -217 M | |
| floaterest income | 0 | 0 | 0 | 0 | |
| floaterest expense | 0 | 0 | 0 | 0 | |
| Other income net | 0 | 0 | 0 | 0 | |
| Pre-tax Income (EBT) | -4 M | 9 M | 23 M | -219 M | |
| Income taxes | -76000 | 1 M | -7 M | -28 M | |
| Net income from total operations | -4 M | 8 M | 31 M | -191 M | |
| Minority floaterest | 0 | 0 | 0 | 0 | |
| Total net income | -3 M | 8 M | 31 M | -188 M | |
| Preferred dividends | N/A | N/A | N/A | N/A | |
| Net income available for common | -4 M | 8 M | 31 M | -191 M | |
| Depreciation | 1 M | 1 M | 2 M | 2 M | |
| Amortization | 0 | 0 | 0 | 0 | |
| Operating income before depreciation (EBITDA) | 3 M | 17 M | 27 M | -215 M | |
| Total Income available for floaterest expense (EBIT) | 0 | 0 | 0 | 0 | |
| Basic EPS total | -0.03 | 0.08 | 0.3 | -1.83 | |
| Diluted EPS total | -0.03 | 0.08 | 0.3 | -1.83 |
Top MarketXLS Rank stocks
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started today
Stand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention
From all of us at MarketXLS, thank you!